Scripps chemist wins national award for neurodegenerative disease research

Chemist Jeffery W. Kelly of Solana Beach, Calif., will be honored August 28 by the worlds largest scientific society for his advances in understanding and developing treatments for rare neurodegenerative diseases. He will receive the 2001 Arthur C. Cope Scholar Award from the American Chemical Society at its national meeting in Chicago.

What we do is design and utilize small molecules to change the course of biology, said Kelly, a chemistry professor and vice president of the Scripps Research Institute in La Jolla, Calif. In particular, we work to prevent neurodegenerative diseases similar to Alzheimers disease but more rare. Disorders that strike fewer than 100,000 people are often called orphan diseases ones too rare for pharmaceutical companies to expect sales to recoup a drugs costs in research, development, and Food and Drug Administration approval.

Thus few if any treatments exist for many of these diseases. But once we make enough progress to get people interested in it, an orphan disease may or may not remain as such, Kelly said. One type of rare disorder his team studies is familial amyloid polyneuropathy (FAP).

At its root is a misshapen version of transthyretin, a blood protein that helps regulate metabolism and nutrition. As in Alzheimers and other amyloid diseases, and for reasons yet unclear, the protein refolds into a new shape that clumps together instead of functioning properly.

What weve done over the years is understand how mutations [in the transthyretin gene] can cause the misshape, he said. Our small molecules can compensate for those mutations. They act as braces to stabilize the normal protein. Several of their molecular braces tailor-made to fit within the proteins three-dimensional structure without blocking its function are now in preclinical trials, he added.


Contact: Rodney Pearson
American Chemical Society

Page: 1

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Protein believed to control formation of memory identified by Scripps & UCSD scientists
3. 22-amino acid bacterium created by Scripps scientists
4. Scripps scientists look deep inside sharks and their high-performance swimming system
5. Scripps research scientist wins 2004 Koch Prize
6. Scripps Research scientists find deafness genes function
7. New approach limits damage after heart attack and improves survival, say Scripps Research scientists
8. Scripps scientists describe dangerous cocktail of alcohol, brain peptides, and neurotransmitters
9. Chemical that turns mouse stem cells into heart muscles discovered by Scripps researchers
10. Structure solved by Scripps scientists shows one way that body controls gene expression
11. Scripps scientists say genetic mutation doesnt protect against HIV and plague

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: